These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6830416)

  • 1. [HPLC determination of azapropazone in human plasma].
    Spahn H; Mutschler E
    Arch Pharm (Weinheim); 1983 Jan; 316(1):42-7. PubMed ID: 6830416
    [No Abstract]   [Full Text] [Related]  

  • 2. The determination of azapropazone in blood plasma.
    Leach H
    Curr Med Res Opin; 1976; 4(1):35-43. PubMed ID: 1261300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the determination of azapropazone from plasma by direct quantitative thin-layer chromatography (author's transl)].
    Geissler HE; Mutschler E; Faust-Tinnefeldt G
    Arzneimittelforschung; 1977; 27(9):1713-5. PubMed ID: 579143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma azapropazone level during combination therapy of rheumatoid diseases].
    Faust-Tinnefeldt G; Geissler HE; Gilfrich HJ
    Verh Dtsch Ges Inn Med; 1978; (84):1502-5. PubMed ID: 311119
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasma level of azapropazone during its combined administration with digitoxin].
    Faust-Tinnefeldt G; Geissler HE; Gilfrich HJ
    Med Welt; 1979 Feb; 30(5):181-2. PubMed ID: 310503
    [No Abstract]   [Full Text] [Related]  

  • 6. [Azapropazone plasma levels under simultaneous treatment with an antacid or laxative].
    Faust-Tinnefeldt G; Geissler HE; Mutschler E
    Arzneimittelforschung; 1977; 27(12):2411-4. PubMed ID: 580058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The determination of azapropazone and its 6-hydroxy metabolite in plasma and urine by HPLC.
    Kline BJ; Wood JH; Beightol LA
    Arzneimittelforschung; 1983; 33(4):504-6. PubMed ID: 6683526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azapropazone binding to human serum albumin.
    Fehske KJ; Jähnchen E; Müller WE; Stillbauer A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):159-63. PubMed ID: 7422015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Azapropazone plasma levels in rheumatologic therapy with D-penicillamine combined with immunosuppressive agents].
    Faust-Tinnefeldt G; Geissler HE; Mutschler E
    Arzneimittelforschung; 1977; 27(11):2153-7. PubMed ID: 580020
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution of azapropazone and its principal 8-hydroxy-metabolite in plasma, urine and gastrointestinal mucosa determined by HPLC.
    Rainsford KD
    J Pharm Pharmacol; 1985 May; 37(5):341-5. PubMed ID: 2862244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aspects of azapropazone and basic therapy of pheumatism considering drug interactions (author's transl)].
    Faust-Tinnefeldt G; Geissler HE
    Arzneimittelforschung; 1977; 27(11):2170-4. PubMed ID: 580024
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma protein binding of azapropazone in patients with kidney and liver disease.
    Jähnchen E; Blanck KJ; Breuing KH; Gilfrich HJ; Meinertz T; Trenk D
    Br J Clin Pharmacol; 1981 Apr; 11(4):361-7. PubMed ID: 7259929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human pharmacokinetics of different i.v. doses of azapropazone (HPLC-determination) (author's transl)].
    Gikalov I; Kaufmann R; Schuster O
    Arzneimittelforschung; 1982; 32(4):423-6. PubMed ID: 7201814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Azapropazone and rheumatic combination therapy considering drug interactions: azapropazone aurothioglucose and azapropazone prednisolone].
    Faust-Tinnefeldt GF; Geissler HE
    Arzneimittelforschung; 1978; 28(2):337-41. PubMed ID: 346022
    [No Abstract]   [Full Text] [Related]  

  • 16. Excretion of azapropazone in human breast milk.
    Bald R; Bernbeck-Betthäuser EM; Spahn H; Mutschler E
    Eur J Clin Pharmacol; 1990; 39(3):271-3. PubMed ID: 2257865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between azapropazone and warfarin.
    McElnay JC; D'Arcy PF
    Experientia; 1978 Oct; 34(10):1320-1. PubMed ID: 738406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of azapropazone following single oral and intravenous doses.
    Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
    Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration of azapropazone in synovial tissues and fluid.
    Spahn H; Thabe K; Mutschler E; Tillmann K; Gikalov I
    Eur J Clin Pharmacol; 1987; 32(3):303-7. PubMed ID: 3595703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic evaluation of the effect of azapropazone on the gastric mucosa.
    Hradsky M; Bruce L
    Scand J Rheumatol; 1978; 7(1):31-2. PubMed ID: 675173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.